| |
|
||||||||||||
![]() |
|
![]() |
|||||||||||
| |
|
|
|
|
|
|
|
|
|||||
| Product Information | |
||||||||||||
![]() |
Elastin | ||||||||||||
|
Exposure of the skin to sun, wind, and other environmental
and lifestyle factors leads to skin aging - loss of moisture, elasticity,
skin tone and texture as the degradation of certain skin proteins takes
place. Further, published medical studies show the ability of cells to
repair the damage by synthesizing replacement elastin declines with age. Developments in the field of molecular biology
now make it possible to produce human tropoelastin in transgenic plants.
To date, human tropoelastin has not been available as a cosmetic ingredient
and human tissue is not used as a source of hydrolyzed elastin. |
|||||||||||||
|
DermaPlus introductory cosmeceutical product, based on the human elastin precursor tropoelastin, is the first to address these issues of declining skin quality and the bodys inability to repair it, with its topical, plant-based and personalized solution. DermaPlus's products and processes offer significant advantages:
KERATIN Study shows that ideal hair treatment products would tailor the type of intact keratin used to match the hair keratins in a specific individuals hair, or reproduce the keratin proteins of hair with desirable characteristics. We envision launching aDermaPlus will launch a second, Keratin-based hair product line, based on the DermaPlus genomic approach, DermaPlus will launch a second Keratin-based hair product line based on the DermaPlus genomic approach within a year after the first product reaches the skin care market. |
|||||||||||||
| top | |||||||||||||
| 1027 Hylan Boulevard, Staten Island, NY 10305 | |||||||||||||